Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Total Non-Current Liabilities (2016 - 2025)

Macrogenics (MGNX) has disclosed Total Non-Current Liabilities for 13 consecutive years, with $200.2 million as the latest value for Q4 2025.

  • Quarterly Total Non-Current Liabilities rose 39.39% to $200.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $200.2 million through Dec 2025, up 39.39% year-over-year, with the annual reading at $200.2 million for FY2025, 39.39% up from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was $200.2 million at Macrogenics, down from $202.4 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $234.0 million in Q1 2023, with the low at $72.1 million in Q3 2022.
  • Average Total Non-Current Liabilities over 5 years is $137.0 million, with a median of $142.5 million recorded in 2024.
  • The sharpest move saw Total Non-Current Liabilities surged 151.66% in 2023, then plummeted 39.36% in 2024.
  • Over 5 years, Total Non-Current Liabilities stood at $95.4 million in 2021, then skyrocketed by 44.91% to $138.2 million in 2022, then grew by 5.32% to $145.5 million in 2023, then decreased by 1.32% to $143.6 million in 2024, then surged by 39.39% to $200.2 million in 2025.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods came in at $200.2 million, $202.4 million, and $197.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.